PE20000646A1 - COMBINATION THERAPY FOR MUSCULOSKELETAL FRAGILITY - Google Patents
COMBINATION THERAPY FOR MUSCULOSKELETAL FRAGILITYInfo
- Publication number
- PE20000646A1 PE20000646A1 PE1999000528A PE00052899A PE20000646A1 PE 20000646 A1 PE20000646 A1 PE 20000646A1 PE 1999000528 A PE1999000528 A PE 1999000528A PE 00052899 A PE00052899 A PE 00052899A PE 20000646 A1 PE20000646 A1 PE 20000646A1
- Authority
- PE
- Peru
- Prior art keywords
- oxo
- phenyl
- combination therapy
- tartrate salt
- musculoskeletal
- Prior art date
Links
- 238000002648 combination therapy Methods 0.000 title 1
- 229940095743 selective estrogen receptor modulator Drugs 0.000 abstract 2
- 239000000333 selective estrogen receptor modulator Substances 0.000 abstract 2
- 208000010392 Bone Fractures Diseases 0.000 abstract 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical class OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 abstract 1
- 102000018997 Growth Hormone Human genes 0.000 abstract 1
- 108010051696 Growth Hormone Proteins 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 239000000122 growth hormone Substances 0.000 abstract 1
- 230000035876 healing Effects 0.000 abstract 1
- FEWJPZIEWOKRBE-LWMBPPNESA-N levotartaric acid Chemical class OC(=O)[C@@H](O)[C@H](O)C(O)=O FEWJPZIEWOKRBE-LWMBPPNESA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 201000001245 periodontitis Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE a)UN MODULADOR DEL RECEPTOR DE ESTROGENOS SELECTIVO (SERM) TAL COMO (-)-CIS-6-FENIL-5-(4-(2-PIRROLIDIN-1-IL-ETOXI)-FENIL)-5,6,7,8-TETRAHIDRONAFTALEN-2-OL O SU SAL D-TARTRATO; b)UN SECRETAGOGO DE LA HORMONA DEL CRECIMIENTO (GHS) TAL COMO 2-AMINO-N-(2-(3a(R)-BENCIL-2-METIL-3-OXO-2,3,3a,4,6,7-HEXAHIDRO-PIRAZOLO[4,3-c]PIRIDIN-5-IL)-1(R)-BENCILOXIMETIL-2-OXO-ETIL)-ISOBUTILAMINA O SU SAL L-TARTRATO. LA COMPOSICION PUEDE SER UTIL PARA EL TRATAMIENTO DE LA FRAGILIDAD MUSCULOESQUELETICA, OSTEOPOROSIS, PERIODONTITIS, CURACION OSEA DESPUES DE UNA RECONSTRUCCION MAXILAR O MANDIBULAR, FRACTURA OSEAREFERS TO A PHARMACEUTICAL COMPOSITION INCLUDING a) A SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM) SUCH AS (-) - CIS-6-PHENYL-5- (4- (2-PYRROLIDIN-1-IL-ETOXY) -PHENYL ) -5,6,7,8-TETRAHIDRONAFTALEN-2-OL OR ITS D-TARTRATE SALT; b) A SECRETAGOG OF GROWTH HORMONE (GHS) SUCH AS 2-AMINO-N- (2- (3a (R) -BENZYL-2-METHYL-3-OXO-2,3,3a, 4,6,7 -HEXAHYDRO-PYRAZOLO [4,3-c] PYRIDIN-5-IL) -1 (R) -BENZYLOXIMETHYL-2-OXO-ETHYL) -ISOBUTYLAMINE OR ITS L-TARTRATE SALT. THE COMPOSITION MAY BE USEFUL FOR THE TREATMENT OF MUSCULOSKELETAL FRAGILITY, OSTEOPOROSIS, PERIODONTITIS, BONE HEALING AFTER A MAXILLARY OR MANDIBULAR RECONSTRUCTION, BONE FRACTURE
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8946998P | 1998-06-16 | 1998-06-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20000646A1 true PE20000646A1 (en) | 2000-08-05 |
Family
ID=22217825
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1999000528A PE20000646A1 (en) | 1998-06-16 | 1999-06-15 | COMBINATION THERAPY FOR MUSCULOSKELETAL FRAGILITY |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP1087764A1 (en) |
| JP (1) | JP2002518326A (en) |
| KR (1) | KR20010052852A (en) |
| CN (1) | CN1301160A (en) |
| AP (1) | AP9901582A0 (en) |
| AR (1) | AR018869A1 (en) |
| AU (1) | AU4054799A (en) |
| BG (1) | BG105041A (en) |
| BR (1) | BR9911324A (en) |
| CA (1) | CA2335134A1 (en) |
| CO (1) | CO5070587A1 (en) |
| EA (1) | EA200001186A1 (en) |
| GT (1) | GT199900087A (en) |
| HN (1) | HN1999000097A (en) |
| HR (1) | HRP20000859A2 (en) |
| HU (1) | HUP0102505A3 (en) |
| ID (1) | ID27599A (en) |
| IL (1) | IL138630A0 (en) |
| IS (1) | IS5691A (en) |
| MA (1) | MA26652A1 (en) |
| NO (1) | NO20006312L (en) |
| OA (1) | OA11505A (en) |
| PA (1) | PA8475901A1 (en) |
| PE (1) | PE20000646A1 (en) |
| PL (1) | PL344981A1 (en) |
| SK (1) | SK18912000A3 (en) |
| TN (1) | TNSN99124A1 (en) |
| TR (1) | TR200003544T2 (en) |
| WO (1) | WO1999065486A1 (en) |
| ZA (1) | ZA993975B (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000047735A2 (en) * | 1999-02-08 | 2000-08-17 | Mcgill University | NON-HUMAN TRANSGENIC ANIMAL WHOSE GERM CELLS AND SOMATIC CELLS CONTAIN A KNOCKOUT MUTATION IN DNA ENCODING ORPHAN NUCLEAR RECEPTOR ERRalpha |
| DE60124616T2 (en) | 2000-05-08 | 2007-09-13 | Pfizer Products Inc., Groton | Enzymatic cleavage of selective modulators of the estrogen receptor |
| IL145106A0 (en) * | 2000-08-30 | 2002-06-30 | Pfizer Prod Inc | Intermittent administration of a geowth hormone secretagogue |
| JP2004507502A (en) * | 2000-08-30 | 2004-03-11 | ファイザー・プロダクツ・インク | Sustained release formulation for growth hormone secretagogue |
| US7476653B2 (en) | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
| WO2006024931A2 (en) * | 2004-08-31 | 2006-03-09 | Pfizer Products Inc. | Therapeutic combinations comprising a selective estrogen receptor modulator and a selective androgen receptor modulator |
| CU23558A1 (en) | 2006-02-28 | 2010-07-20 | Ct Ingenieria Genetica Biotech | COMPOUNDS ANALOG TO THE PEPTIDIC SECRETAGOGS OF THE GROWTH HORMONE |
| ES2604943T3 (en) | 2007-02-09 | 2017-03-10 | Ocera Therapeutics, Inc. | Ghrelin receptor macrocyclic modulators and procedures for their use |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA51676C2 (en) * | 1995-11-02 | 2002-12-16 | Пфайзер Інк. | (-)cis-6(S)-phenyl-5(R)-[4-(2-pyrrolidin-I-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol D-tartrate, a method of its preparation, method of THE treatment OF diseases medicated by agonists of estrogen and a pharmaceutical composition |
| TW432073B (en) * | 1995-12-28 | 2001-05-01 | Pfizer | Pyrazolopyridine compounds |
| HN1996000101A (en) * | 1996-02-28 | 1997-06-26 | Inc Pfizer | COMBINED THERAPY FOR OSTEOPOROSIS |
-
1999
- 1999-06-15 HN HN1999000097A patent/HN1999000097A/en unknown
- 1999-06-15 PA PA19998475901A patent/PA8475901A1/en unknown
- 1999-06-15 PE PE1999000528A patent/PE20000646A1/en not_active Application Discontinuation
- 1999-06-15 ZA ZA9903975A patent/ZA993975B/en unknown
- 1999-06-15 AP APAP/P/1999/001582A patent/AP9901582A0/en unknown
- 1999-06-15 AR ARP990102848A patent/AR018869A1/en not_active Application Discontinuation
- 1999-06-16 TN TNTNSN99124A patent/TNSN99124A1/en unknown
- 1999-06-16 ID IDW20002627A patent/ID27599A/en unknown
- 1999-06-16 CN CN99806237A patent/CN1301160A/en active Pending
- 1999-06-16 MA MA25628A patent/MA26652A1/en unknown
- 1999-06-16 PL PL99344981A patent/PL344981A1/en not_active Application Discontinuation
- 1999-06-16 HR HR20000859A patent/HRP20000859A2/en not_active Application Discontinuation
- 1999-06-16 WO PCT/IB1999/001117 patent/WO1999065486A1/en not_active Ceased
- 1999-06-16 GT GT199900087A patent/GT199900087A/en unknown
- 1999-06-16 JP JP2000554366A patent/JP2002518326A/en active Pending
- 1999-06-16 EP EP99923802A patent/EP1087764A1/en not_active Withdrawn
- 1999-06-16 BR BR9911324-4A patent/BR9911324A/en not_active Application Discontinuation
- 1999-06-16 KR KR1020007014186A patent/KR20010052852A/en not_active Ceased
- 1999-06-16 HU HU0102505A patent/HUP0102505A3/en unknown
- 1999-06-16 EA EA200001186A patent/EA200001186A1/en unknown
- 1999-06-16 TR TR2000/03544T patent/TR200003544T2/en unknown
- 1999-06-16 CO CO99037622A patent/CO5070587A1/en unknown
- 1999-06-16 SK SK1891-2000A patent/SK18912000A3/en unknown
- 1999-06-16 IL IL13863099A patent/IL138630A0/en unknown
- 1999-06-16 AU AU40547/99A patent/AU4054799A/en not_active Abandoned
- 1999-06-16 CA CA002335134A patent/CA2335134A1/en not_active Abandoned
-
2000
- 2000-10-20 OA OA1200000290A patent/OA11505A/en unknown
- 2000-10-27 IS IS5691A patent/IS5691A/en unknown
- 2000-12-11 BG BG105041A patent/BG105041A/en unknown
- 2000-12-12 NO NO20006312A patent/NO20006312L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CO5070587A1 (en) | 2001-08-28 |
| TR200003544T2 (en) | 2001-04-20 |
| ID27599A (en) | 2001-04-12 |
| MA26652A1 (en) | 2004-12-20 |
| OA11505A (en) | 2004-05-07 |
| EP1087764A1 (en) | 2001-04-04 |
| GT199900087A (en) | 2000-12-07 |
| PA8475901A1 (en) | 2000-05-24 |
| TNSN99124A1 (en) | 2005-11-10 |
| SK18912000A3 (en) | 2001-10-08 |
| KR20010052852A (en) | 2001-06-25 |
| NO20006312D0 (en) | 2000-12-12 |
| ZA993975B (en) | 2000-12-15 |
| PL344981A1 (en) | 2001-11-19 |
| HN1999000097A (en) | 1999-11-03 |
| HUP0102505A3 (en) | 2002-12-28 |
| CN1301160A (en) | 2001-06-27 |
| AU4054799A (en) | 2000-01-05 |
| WO1999065486A1 (en) | 1999-12-23 |
| BG105041A (en) | 2001-08-31 |
| IS5691A (en) | 2000-10-27 |
| HRP20000859A2 (en) | 2001-04-30 |
| NO20006312L (en) | 2000-12-12 |
| EA200001186A1 (en) | 2001-06-25 |
| BR9911324A (en) | 2001-04-03 |
| JP2002518326A (en) | 2002-06-25 |
| AR018869A1 (en) | 2001-12-12 |
| CA2335134A1 (en) | 1999-12-23 |
| AP9901582A0 (en) | 1999-06-30 |
| HUP0102505A2 (en) | 2001-11-28 |
| IL138630A0 (en) | 2001-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20020722A1 (en) | DERIVATIVES OF GLUCOPYRANOSILOXIPYRAZOL AS AN INHIBITOR OF HUMAN SGLT2 | |
| ECSP066313A (en) | DERIVATIVES OF PIRIDAZINE AND ITS USE AS THERAPEUTIC AGENTS | |
| ECSP066315A (en) | DERIVATIVES OF PIRIDAZINE AND ITS USE AS THERAPEUTIC AGENTS | |
| CO5271691A1 (en) | NEW COMPOUNDS | |
| ECSP066312A (en) | PIRIDILO DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS | |
| BR0110767A (en) | Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity | |
| BG107697A (en) | Ep4 receptor selective agonists in the treatment of osteoporosis | |
| AP2001002357A0 (en) | EP4 receptor selective agonists in the treatment of osteoporosis. | |
| SV2002000696A (en) | IMIDAZOL COMPOUNDS CONDENSED WITH ARILO OR HETEROARILO AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS PC9985AHXK / BB | |
| MY144992A (en) | Substituted 1,2,3,4-tetrahydroisoquinoline derivatives. | |
| PA8493701A1 (en) | COMPOUNDS TO TREAT OBESITY | |
| DK1317419T3 (en) | Cyanophenoxycarboxylic acid compounds and compositions to deliver active agents | |
| BR0015624A (en) | Use of a compound, compound, pharmaceutical composition, and method of treatment or prophylaxis of human diseases or conditions | |
| NO20022442D0 (en) | Medicines for diseases related to reduction in bone mass | |
| CU23241B7 (en) | 2-PHENYL-1- (4 (2-AMINOETOXI) -BENZIL) -INDOL IN COMBINATION WITH STROGENS | |
| ATE327974T1 (en) | MODULATORS OF THE GLUCOCORTICOID RECEPTOR | |
| MY133503A (en) | Selective iglur5 receptor antagonists for the treatment of migrane | |
| TW200633978A (en) | 2,3,4,9-tetrahydro-1H-carbazole derivatives as crth2 receptor antagonists | |
| PE20000646A1 (en) | COMBINATION THERAPY FOR MUSCULOSKELETAL FRAGILITY | |
| PE20030944A1 (en) | INDOLYL-UREA DERIVED FROM THENOPYRIDINES USEFUL AS ANTIANGIOGENIC AGENTS AND PROCEDURES FOR THEIR USE | |
| UA84896C2 (en) | Hydronopol derivatives as agonists on human orl1 receptors | |
| PE20000644A1 (en) | THERAPEUTIC COMBINATIONS INCLUDING A SELECTIVE ESTROGEN RECEPTOR MODULATOR AND PARATHYROID HORMONE | |
| BR0211932A (en) | Methods and compositions for oral administration of parathyroid hormone, pth | |
| AU2284001A (en) | Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone | |
| PE122699A1 (en) | VITRONECTIN RECEPTOR ANTAGONISTS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |